HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

Clinical trial NCT05360381 · UNKNOWN

Trial details

NCT number: NCT05360381
Sponsor: Shanghai Henlius Biotech
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors Squamous-cell Non-small Cell Lung Cancer

Start date: 2022-06-03
Primary completion: 2024-10-30
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.